Edward Mayerson
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Vascular Tumors and Angiosarcomas
- CAR-T cell therapy research
-
- Sarcoma Diagnosis and Treatment
Papers in
- Oncology 13
- Peptidase Inhibition and Analysis 5
- Cancer Immunotherapy and Biomarkers 4
- Bone health and treatments 3
- Vascular Tumors and Angiosarcomas 2
- Lung Cancer Research Studies 2
-
- Prostate Cancer Treatment and Research 3
- Co-authors
- Young Kwang Chae (9 shared papers)Razelle Kurzrock (9 shared papers)Elad Sharon (8 shared papers)Melissa Plets (8 shared papers)Megan Othus (9 shared papers)Sandip Pravin Patel (8 shared papers)Charles D. Blanke (7 shared papers)Christine M. McLeod (5 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer Research (2 papers)Cancer (1 paper)Prostate Cancer and Prostatic Diseases (1 paper)Public Health Reports (1 paper)
- Partner nations
- United States
In The Last Decade
Edward Mayerson
13 papers receiving 258 citations
Peers
Comparison fields: 5 of 38
- Oncology 211
- Pulmonary and Respiratory Medicine 110
- Neurology 49
- Epidemiology 75
- Cardiology and Cardiovascular Medicine 44
Countries citing papers authored by Edward Mayerson
This map shows the geographic impact of Edward Mayerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Mayerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Mayerson more than expected).
Fields of papers citing papers by Edward Mayerson
This network shows the impact of papers produced by Edward Mayerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Mayerson. The network helps show where Edward Mayerson may publish in the future.
Co-authors
The 25 scholars most cited alongside Edward Mayerson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 106 | |
| 2 | 2021 | 74 | |
| 3 | 2020 | 21 | |
| 4 | 2019 | 13 | |
| 5 | 2020 | 9 | |
| 6 | 2016 | 9 | |
| 7 | 2022 | 7 | |
| 8 | 2020 | 5 | |
| 9 | 2020 | 5 | |
| 10 | 2023 | 4 | |
| 11 | 2022 | 2 | |
| 12 | 2020 | 2 | |
| 13 | 2022 | 2 | |
| 14 | 2024 | 0 |
About Edward Mayerson
Edward Mayerson is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 14 papers that have together received 259 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Bone health and treatments (3 papers), Prostate Cancer Treatment and Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Vascular Tumors and Angiosarcomas (2 papers), Lung Cancer Research Studies (2 papers) and Cardiac tumors and thrombi (2 papers). The work is most often cited by research in Oncology (211 citations), Pulmonary and Respiratory Medicine (110 citations), Neurology (49 citations), Epidemiology (75 citations) and Cardiology and Cardiovascular Medicine (44 citations). Edward Mayerson has collaborated with scholars based in United States. Frequent co-authors include Young Kwang Chae, Razelle Kurzrock, Elad Sharon, Melissa Plets, Megan Othus, Sandip Pravin Patel, Charles D. Blanke, Christine M. McLeod, Rashmi Chugh and Christopher W. Ryan. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Cancer, Prostate Cancer and Prostatic Diseases and Public Health Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.